Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants
Active, not recruitingOBSERVATIONAL
Enrollment
2,400
Participants
Timeline
Start Date
January 13, 2025
Primary Completion Date
May 30, 2026
Study Completion Date
May 30, 2026
Conditions
Respiratory Syncytial Virus Immunization
Trial Locations (1)
Unknown
Germany
All Listed Sponsors
lead
Sanofi Pasteur, a Sanofi Company
INDUSTRY
NCT06824207 - Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants | Biotech Hunter | Biotech Hunter